Health & Medicine

McMaster's Acting Vice-President of Research, Allison Sekuler was recently in the Netherlands to explore and expand partnership opportunities and share best practices in university research and innovation.

Researchers at the CanChild Centre for Childhood Disability Research have developed an autism classification system that defines levels of social communications ability among those with autism spectrum disorder.

McMaster is exploring Research and Development and commercialization opportunities in Israel as part of a week-long business mission to the Middle East led by Ontario Premier Kathleen Wynne.

Dr. John Kelton was invested as a Member of the Order of Canada last week.

Proposed rule changes by Major League Baseball, designed to speed up the game by reducing time between pitches, could lead to a spike in arm injuries, say researchers who have analyzed the impact of fatigue.

McMaster's Associate Vice-President, International Affairs, Peter Mascher, will join Ontario Premier Kathleen Wynne on a week-long business mission to Israel and the West Bank.

McMaster will lead a project to innovate the way patients stay connected with their physicians through electronic platform that enables remote monitoring and better communications between patients and physicians.

"It affects a vulnerable population of children and youth, can impact social interactions amongst youth and, as our research shows, can drive health issues," says associate professor Dr. Katherine Morrison.

Researchers have revealed how a female sex hormone present during the menstrual cycle may work to protect women against sexually transmitted viral infections.

Among the recipients are two researchers taking on infectious diseases in two very different ways.

Research will look at how toxicants such as pesticides and herbicides and ingredients like artificial sweeteners and high-fructose corn syrup might affect brown fat activity.

The discovery provides new strategies that can be used to control the growth of cells used as therapeutics for a range of life-threatening diseases.